Abstract
Microtubules are high dynamic protein filaments fundamental for cells growth and proliferation. Hence, tubulin inhibitors are useful anticancer compounds. Three major binding site have been identified in tubulin, on the basis of known ligands: the vinca domain, the colchicine domain and the taxane domain. Several compounds able to bind the colchicine and the taxane domains have been to date synthesized and evaluated. In this review we give a description of the developed QSAR and 3D-QSAR models, giving particular attention to those studies that give structural insight in the binding modes of compounds with the target.
Keywords: Colchicine, combretastatin, comfa, epothilones, QSAR, taxanes.
Current Topics in Medicinal Chemistry
Title:QSAR and 3D-QSAR Models in the Field of Tubulin Inhibitors as Anticancer Agents
Volume: 14 Issue: 20
Author(s): Giovanni Marzaro and Adriana Chilin
Affiliation:
Keywords: Colchicine, combretastatin, comfa, epothilones, QSAR, taxanes.
Abstract: Microtubules are high dynamic protein filaments fundamental for cells growth and proliferation. Hence, tubulin inhibitors are useful anticancer compounds. Three major binding site have been identified in tubulin, on the basis of known ligands: the vinca domain, the colchicine domain and the taxane domain. Several compounds able to bind the colchicine and the taxane domains have been to date synthesized and evaluated. In this review we give a description of the developed QSAR and 3D-QSAR models, giving particular attention to those studies that give structural insight in the binding modes of compounds with the target.
Export Options
About this article
Cite this article as:
Marzaro Giovanni and Chilin Adriana, QSAR and 3D-QSAR Models in the Field of Tubulin Inhibitors as Anticancer Agents, Current Topics in Medicinal Chemistry 2014; 14(20) . https://dx.doi.org/10.2174/1568026614666141130092853
DOI https://dx.doi.org/10.2174/1568026614666141130092853 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Practical Approach to Diagnosis and Treatment of Symptomatic Thromboembolic Events in Children with Acute Lymphoblastic Leukemia: Recommendations of the “Coagulation Defects” AIEOP Working Group
Recent Patents on Cardiovascular Drug Discovery Development and biological studies of <sup>177</sup>Lu-DOTA-rituximab for the treatment of Non-Hodgkin’s lymphoma
Current Radiopharmaceuticals Emerging Technologies for Fertility Preservation in Female Patients
Current Women`s Health Reviews CD47 Functionalization of Nanoparticles as a Poly(ethylene glycol) Alternative: A Novel Approach to Improve Drug Delivery
Current Drug Targets Prokinetic Agents and QT Prolongation: A Familiar Scene with New Actors
Current Drug Safety Association of Viruses in the Development of Cardiovascular Diseases
Current Pharmaceutical Design Recent Progress in the Identification and Clinical Evaluation of Inhibitors of the Mitotic Kinesin KSP
Current Topics in Medicinal Chemistry Erythropoietin and Oxidative Stress
Current Neurovascular Research Neuronal Death in Amyotrophic Lateral Sclerosis (ALS): What Can We Learn from Genetics?
CNS & Neurological Disorders - Drug Targets Expansion of Umbilical Cord Blood for Clinical Transplantation
Current Stem Cell Research & Therapy Adenosine Receptors: What We Know and What We are Learning
Current Topics in Medicinal Chemistry LC-HRMS and NMR Analysis of Lyophilized Acmella oleracea Capitula, Leaves and Stems
The Natural Products Journal Aromatase: The Enzyme and Its Inhibition
Anti-Cancer Agents in Medicinal Chemistry Proline-Directed Protein Kinase FA as a Potential Target for Diagnosis and Therapy of Human Cancers
Current Cancer Drug Targets Editorial (Thematic Issue: Targeting Mammalian Spermatogenesis: A Matter of Support)
Current Molecular Pharmacology The Efficacy and Safety of Additional Anti-HER2-Targeting Drugs in the Treatment of HER2-Positive Advanced Breast Cancer: A Meta-Analysis
Anti-Cancer Agents in Medicinal Chemistry Bioprospecting for Functionally-Proficient Potential Probiotics
Current Nutrition & Food Science Thirty Years of Polyamine-Related Approaches to Cancer Therapy. Retrospect and Prospect. Part 1. Selective Enzyme Inhibitors
Current Drug Targets The Role of Brain Gaseous Transmitters in the Regulation of the Circulatory System
Current Pharmaceutical Biotechnology Neural Differentiation and Therapeutic Potential of Adipose Tissue Derived Stem Cells
Current Stem Cell Research & Therapy